German (DAX) Drug Retail Industry Analysis
UpdatedJun 24, 2024
DataAggregated Company Financials
Companies1
- 7D4.5%
- 3M-20.7%
- 1Y31.8%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 2.4%, driven by gains from every company within the industry. In the last 12 months, the industry was up 25%. Looking forward, earnings are forecast to grow by 47% annually.
Industry Valuation and Performance
Has the German Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 24 Jun 2024 | €2.4b | €2.0b | -€9,624,000.00 | n/a | -247.7x | 1.2x |
| Wed, 22 May 2024 | €2.0b | €2.0b | -€9,624,000.00 | n/a | -207.1x | 1x |
| Fri, 19 Apr 2024 | €2.7b | €1.8b | -€12,041,000.00 | n/a | -226.2x | 1.5x |
| Sun, 17 Mar 2024 | €2.8b | €1.8b | -€12,041,000.00 | n/a | -236.6x | 1.6x |
| Tue, 13 Feb 2024 | €2.7b | €1.6b | -€16,228,000.00 | n/a | -167.1x | 1.7x |
| Thu, 11 Jan 2024 | €2.4b | €1.6b | -€16,228,000.00 | n/a | -146.5x | 1.5x |
| Sat, 09 Dec 2023 | €2.4b | €1.6b | -€16,228,000.00 | n/a | -149.4x | 1.5x |
| Mon, 06 Nov 2023 | €2.0b | €1.6b | -€16,228,000.00 | n/a | -120.7x | 1.2x |
| Wed, 04 Oct 2023 | €1.9b | €1.4b | -€44,668,000.00 | n/a | -41.8x | 1.3x |
| Fri, 01 Sep 2023 | €2.0b | €1.4b | -€44,668,000.00 | n/a | -44.8x | 1.4x |
| Sun, 30 Jul 2023 | €1.9b | €1.3b | -€64,936,000.00 | n/a | -29.1x | 1.5x |
| Tue, 27 Jun 2023 | €1.6b | €1.3b | -€64,936,000.00 | n/a | -24.6x | 1.3x |
| Thu, 25 May 2023 | €1.7b | €1.3b | -€64,936,000.00 | n/a | -26.8x | 1.4x |
| Sat, 22 Apr 2023 | €1.6b | €1.2b | -€77,646,000.00 | n/a | -20.7x | 1.3x |
| Mon, 20 Mar 2023 | €1.3b | €1.2b | -€77,646,000.00 | n/a | -17.1x | 1.1x |
| Wed, 15 Feb 2023 | €1.2b | €1.2b | -€110,362,000.00 | n/a | -10.7x | 1x |
| Fri, 13 Jan 2023 | €1.2b | €1.2b | -€110,362,000.00 | n/a | -10.5x | 1x |
| Sun, 11 Dec 2022 | €820.6m | €1.2b | -€110,362,000.00 | n/a | -7.4x | 0.7x |
| Tue, 08 Nov 2022 | €806.5m | €1.2b | -€110,362,000.00 | n/a | -7.3x | 0.7x |
| Thu, 06 Oct 2022 | €783.0m | €1.1b | -€104,980,000.00 | n/a | -7.5x | 0.7x |
| Sat, 03 Sep 2022 | €983.7m | €1.1b | -€104,980,000.00 | n/a | -9.4x | 0.9x |
| Mon, 01 Aug 2022 | €1.7b | €1.1b | -€91,327,000.00 | n/a | -18.8x | 1.6x |
| Wed, 29 Jun 2022 | €1.6b | €1.1b | -€91,327,000.00 | n/a | -17.9x | 1.5x |
| Fri, 27 May 2022 | €1.7b | €1.1b | -€91,327,000.00 | n/a | -18.3x | 1.5x |
| Sun, 24 Apr 2022 | €1.3b | €1.1b | -€74,185,000.00 | n/a | -17x | 1.2x |
| Tue, 22 Mar 2022 | €1.6b | €1.1b | -€74,185,000.00 | n/a | -21.1x | 1.5x |
| Thu, 17 Feb 2022 | €1.8b | €1.0b | -€39,014,000.00 | n/a | -45.3x | 1.7x |
| Sat, 15 Jan 2022 | €2.0b | €1.0b | -€39,014,000.00 | n/a | -50.2x | 1.9x |
| Mon, 13 Dec 2021 | €2.4b | €1.0b | -€39,014,000.00 | n/a | -62.4x | 2.3x |
| Wed, 10 Nov 2021 | €2.7b | €1.0b | -€39,014,000.00 | n/a | -68.6x | 2.6x |
Price to Earnings Ratio
-68.6x
Current Industry PE
- There is only one company in the German Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have improved over the last three years.
- Revenues for these companies have grown 24% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does German Drug Retail compare with similar industries?
| DE Market | 0.0078% | |
| Consumer Staples | -2.04% | |
| Food and Staples Retail | 0.73% | |
| Drug Retail | 4.55% | |
| Food Distributors | 1.85% | |
| Big Box Super Stores | 0% | |
| Food Retail | -7.90% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RDC Redcare Pharmacy | €117.20 | 4.7% +€107.8m | 33.6% | PS1.2x |